Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition
Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the…
Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the…
Recent research from GlobalData analyzed the Net Zero strategies of the world’s top 18 pharmaceutical companies by revenue. All of…
The pharmaceutical industry is on the brink of a remarkable transformation over the next ten years. As the demand for…
Pharmaceutical supply chains are some of the world’s most intricate. Recent developments have only heightened the challenges for companies on…
Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to…
Disruption is a pressing problem in the pharmaceutical world; patient health depends on the smooth and predictable movement of resources…
Cancer, once primarily perceived as a disease of the elderly, is now becoming a major concern for young adults. The…
Pharmaceutical supply chains are among the world’s most complex. And for firms on the frontline, that is increasingly problematic. According…
Global demand for drugs of all kinds is increasing. GlobalData’s drugs database forecasts global drug sales, from 2024 to 2030,…
In the wake of the Covid-19 vaccine, mRNA research and development increased dramatically. However, as the demand for Covid-19 vaccines…